CorMedix Inc. Quarterly Debt-to-equity in % from Q1 2012 to Q2 2024

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
CorMedix Inc. quarterly Debt-to-equity history and growth rate from Q1 2012 to Q2 2024.
  • CorMedix Inc. Debt-to-equity for the quarter ending June 30, 2024 was 16.2 %, a 33.4% increase year-over-year.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date
Q2 2024 16.2 +4.05 +33.4% Jun 30, 2024
Q1 2024 14.7 +4.05 +38.2% Mar 31, 2024
Q4 2023 13 +2.82 +27.6% Dec 31, 2023
Q3 2023 11.8 +2.26 +23.7% Sep 30, 2023
Q2 2023 12.1 +2.98 +32.5% Jun 30, 2023
Q1 2023 10.6 +2.7 +34.2% Mar 31, 2023
Q4 2022 10.2 +3.27 +47% Dec 31, 2022
Q3 2022 9.55 +2.51 +35.7% Sep 30, 2022
Q2 2022 9.17 +1.3 +16.5% Jun 30, 2022
Q1 2022 7.9 -3.53 -30.9% Mar 31, 2022
Q4 2021 6.96 -11.7 -62.7% Dec 31, 2021
Q3 2021 7.04 -16.3 -69.8% Sep 30, 2021
Q2 2021 7.87 -16.3 -67.4% Jun 30, 2021
Q1 2021 11.4 -19.2 -62.7% Mar 31, 2021
Q4 2020 18.7 -19.6 -51.3% Dec 31, 2020
Q3 2020 23.3 -37.8 -61.9% Sep 30, 2020
Q2 2020 24.2 -163 -87.1% Jun 30, 2020
Q1 2020 30.7 -962 -96.9% Mar 31, 2020
Q4 2019 38.3 +554 Dec 31, 2019
Q3 2019 61.1 +628 Sep 30, 2019
Q2 2019 187 -94.8 -33.6% Jun 30, 2019
Q1 2019 993 +917 +1210% Mar 31, 2019
Q4 2018 -516 -562 -1205% Dec 31, 2018
Q3 2018 -566 -600 -1794% Sep 30, 2018
Q2 2018 282 +254 +919% Jun 30, 2018
Q1 2018 75.8 +55.7 +278% Mar 31, 2018
Q4 2017 46.7 +31.3 +204% Dec 31, 2017
Q3 2017 33.4 +21.1 +171% Sep 30, 2017
Q2 2017 27.7 +18.2 +192% Jun 30, 2017
Q1 2017 20.1 +12 +150% Mar 31, 2017
Q4 2016 15.4 +6.56 +74.6% Dec 31, 2016
Q3 2016 12.4 +2.32 +23.1% Sep 30, 2016
Q2 2016 9.49 -3.24 -25.4% Jun 30, 2016
Q1 2016 8.01 -88.9 -91.7% Mar 31, 2016
Q4 2015 8.8 -663 -98.7% Dec 31, 2015
Q3 2015 10 +847 Sep 30, 2015
Q2 2015 12.7 +295 Jun 30, 2015
Q1 2015 96.9 +310 Mar 31, 2015
Q4 2014 672 +826 Dec 31, 2014
Q3 2014 -837 -680 -433% Sep 30, 2014
Q2 2014 -282 -86.3 -44.1% Jun 30, 2014
Q1 2014 -213 +103 +32.5% Mar 31, 2014
Q4 2013 -154 +1.05K +87.2% Dec 31, 2013
Q3 2013 -157 -646 -132% Sep 30, 2013
Q2 2013 -196 -464 -173% Jun 30, 2013
Q1 2013 -316 -435 -364% Mar 31, 2013
Q4 2012 -1.2K Dec 31, 2012
Q3 2012 489 Sep 30, 2012
Q2 2012 269 Jun 30, 2012
Q1 2012 120 Mar 31, 2012
* An asterisk sign (*) next to the value indicates that the value is likely invalid.